Then, we first analyzed the expression levels of PD-1 and PD-L1 in the GSDMD low- and high-level glioma patients and found that both PD-1 and PD-L1 had significant upregulation in the highly expressed GSDMD patients (p < 0.0001, Figure 6A). The gene discussed is CD274; the disease is central nervous system cancer.